All 34 HGSOCs (100%) showed aberrant p53 immunohistochemical expression, whereas the two study controls (LGSOC and mucinous carcinoma) had wild-type TP53, with p53 expression respectively 20% and 5% (Supplementary Figure 1). The gene discussed is TP53; the disease is mucinous adenocarcinoma.